Skip to main content
Clinical Trials/ChiCTR1900025771
ChiCTR1900025771Not yet recruitingUnknown

Crowdsourcing to Promote Hepatitis C Testing and Linkage-to-care in China: a Randomized Controlled Trial Protocol

Conquering Hepatitis via Micro-Elimination (CHIME) grant (ref no: IN-CN-987-5376)1 site in 1 country1,006 target enrollmentStarted: September 2, 2019Last updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
1,006
Locations
1
Primary Endpoint
Number of HCV antibody screening test uptake

Study Overview

Brief Summary

Specific aim 1: To compare the effects of a crowdsourcing intervention to the control on HCV test uptake among patients attending the primary care department in a tertiary hospital in China. Hypothesis 1: A crowdsourced intervention will be superior to the control in promoting HCV test uptake among patients attending the primary care department in a tertiary hospital in China.

Study Design

Study Type
Interventional
Primary Purpose
随机平行对照
Masking
None

Eligibility Criteria

Ages
30 to 100 (—)
Sex
All

Inclusion Criteria

  • Participants will be invited to participate if they are 30 years old or older, a Chinese, and will reside in Shenzhen for the following month.

Exclusion Criteria

  • Participants will be excluded if they self-report one of the followings: known chronic HCV infection, testing for serum anti-HCV in the past 12 months, current or planned pregnancy, currently undergoing complex medical treatment for other conditions.

Arms & Interventions

Group 2

Crowd-sourcing contest materials to increase HCV uptake

Group 1

Standard of care on HCV testing uptake

Outcomes

Primary Outcomes

Number of HCV antibody screening test uptake

Secondary Outcomes

  • Number of participants that additionally self-report HBsAg testing with/without confirmation by medical records or HBsAg viral load confirmatory testing
  • Rate of participation in the crowdsourcing intervention
  • Content of feedback submissions
  • Number of participants that self-report HCV antibody testing but are not confirmed by medical records
  • Number of participants that enrol in VCT service at HKU-SZH
  • Number of participants that follow-up for HCV confirmatory testing
  • Number of participants that join the peer training program at HKU-SZH
  • Number of HCV diagnosed participants to continue with anti-HCV treatment, versus those who decline treatment for any reason
  • Number of participants that will be completely cured of HCV infection, versus number that drop out prior to completing treatment
  • Number of participants diagnosed with chronic liver disease (including cirrhosis, liver failure, or hepatocellular carcinoma)
  • Number of participants that will return to primary care for chronic liver disease follow-up or future screening of HCV and other conditions

Investigators

Sponsor
Conquering Hepatitis via Micro-Elimination (CHIME) grant (ref no: IN-CN-987-5376)

Study Sites (1)

Loading locations...

Similar Trials